Literature DB >> 16032389

HLA-B27 polymorphism in Turkish patients with ankylosing spondylitis.

Asuman Birinci1, Ayhan Bilgici, Omer Kuru, Belma Durupinar.   

Abstract

The aim of this study was to determine the distribution of human leukocyte antigen (HLA)-B27 subtypes in serologically HLA-B27-positive ankylosing spondylitis (AS) patients and healthy controls from the Turkish population and to compare this with other reports from other populations. We subtyped HLA-B27 in 38 HLA-B27-positive Turkish patients with AS and 47 HLA-B27-positive healthy controls without AS by polymerase chain reaction with specific sequence primers (PCR-SSP). The results demonstrated that: B*2705 was the predominant subtype among both of the patients (71.1%) and controls (68.0%). B*2702 was observed in 26.3% and 32.0% of the patients and controls, respectively. B*2708 subtype was found in 2.6% of the patients but not among the control group. When the distribution of B27 subtypes in Turkish populations was compared with that in other populations, similar frequencies with the Caucasian-Europe groups were noted. However, this should be interpreted carefully because of the small number of individuals in our study.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16032389     DOI: 10.1007/s00296-005-0614-x

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  12 in total

1.  Nomenclature for factors of the HLA system, 2000.

Authors:  S G Marsh; J G Bodmer; E D Albert; W F Bodmer; R E Bontrop; B Dupont; H A Erlich; J A Hansen; B Mach; W R Mayr; P Parham; E W Petersdorf; T Sasazuki; G M Schreuder; J L Strominger; A Svejgaard; P I Terasaki
Journal:  Hum Immunol       Date:  2001-04       Impact factor: 2.850

2.  Interethnic genetic differentiation: HLA class I antigens in the population of Mongolia.

Authors:  Nyam-Osorin Chimge; Jamiyangiin Batsuuri
Journal:  Am J Hum Biol       Date:  1999-09       Impact factor: 1.937

3.  HLA-B27 polymorphism and worldwide susceptibility to ankylosing spondylitis.

Authors:  S Gonzalez-Roces; M V Alvarez; S Gonzalez; A Dieye; H Makni; D G Woodfield; L Housan; V Konenkov; M C Abbadi; N Grunnet; E Coto; C López-Larrea
Journal:  Tissue Antigens       Date:  1997-02

4.  A simple salting out procedure for extracting DNA from human nucleated cells.

Authors:  S A Miller; D D Dykes; H F Polesky
Journal:  Nucleic Acids Res       Date:  1988-02-11       Impact factor: 16.971

Review 5.  HLA-B27 and genetic predisposing factors in spondyloarthropathies.

Authors:  J D Reveille; E J Ball; M A Khan
Journal:  Curr Opin Rheumatol       Date:  2001-07       Impact factor: 5.006

6.  HLA-B27 subtypes in Asian patients with ankylosing spondylitis. Evidence for new associations.

Authors:  C López-Larrea; K Sujirachato; N K Mehra; P Chiewsilp; D Isarangkura; U Kanga; O Dominguez; E Coto; M Penã; F Setién
Journal:  Tissue Antigens       Date:  1995-03

7.  Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria.

Authors:  S van der Linden; H A Valkenburg; A Cats
Journal:  Arthritis Rheum       Date:  1984-04

8.  HLA B27 polymorphism in Western India.

Authors:  U Shankarkumar; K Ghosh; D Mohanty
Journal:  Tissue Antigens       Date:  2002-07

9.  HLA-B27 subtypes determination in patients with ankylosing spondylitis from Zulia, Venezuela.

Authors:  Ana Cipriani; Sergio Rivera; Manzur Hassanhi; Georgina Márquez; Rosaura Hernández; Cecilia Villalobos; Milagros Montiel
Journal:  Hum Immunol       Date:  2003-07       Impact factor: 2.850

10.  HLA-B27 and its subtypes in 4 Taiwanese Aborigine tribes: a comparison to Han Chinese patients with ankylosing spondylitis.

Authors:  Chung T Chou; Jia M Chen; Chang M Hsu; Shu J Chen
Journal:  J Rheumatol       Date:  2003-02       Impact factor: 4.666

View more
  6 in total

1.  The association of HLA-B*27 subtypes with ankylosing spondylitis in Wuhan population of China.

Authors:  Xiang Liu; Li-Hua Hu; Yi-Rong Li; Feng-Hua Chen; Yong Ning; Qun-Feng Yao
Journal:  Rheumatol Int       Date:  2009-06-18       Impact factor: 2.631

2.  HLA-B27 subtypes in Turkish patients with ankylosing spondylitis and healthy controls.

Authors:  Muradiye Acar; Tulin Cora; Recep Tunc; Hasan Acar
Journal:  Rheumatol Int       Date:  2011-09-17       Impact factor: 2.631

Review 3.  An Update on the Genetic Polymorphism of HLA-B*27 With 213 Alleles Encompassing 160 Subtypes (and Still Counting).

Authors:  Muhammad A Khan
Journal:  Curr Rheumatol Rep       Date:  2017-02       Impact factor: 4.592

4.  Association of HLA-B27 with ankylosing spondylitis and clinical features of the HLA-B27-associated ankylosing spondylitis: a meta-analysis.

Authors:  Hai Lin; Yi-Zhen Gong
Journal:  Rheumatol Int       Date:  2017-05-19       Impact factor: 2.631

5.  HLA-B27 testing: A journey from flow cytometry to molecular subtyping.

Authors:  Pratiksha Chheda; Sandeep Warghade; Jyothi Mathias; Tavisha Dama; Sunmeet Matkar; Nilesh Shah; Rajesh Bendre
Journal:  J Clin Lab Anal       Date:  2018-01-19       Impact factor: 2.352

6.  Comparison of HLA-B*27 subtypes between Chinese patients with ankylosing spondylitis and non-ankylosing spondylitis carriers.

Authors:  Fangjun Luo; Zhigang Zhao; Jie Zhang; Jianhang Leng
Journal:  J Int Med Res       Date:  2019-06-10       Impact factor: 1.671

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.